- Home
- Publications
- Publication Search
- Publication Details
Title
Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 17, Issue 11, Pages 1158-1167
Publisher
Informa UK Limited
Online
2016-09-22
DOI
10.1080/15384047.2016.1235663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein
- (2015) N. Koshikawa et al. CANCER RESEARCH
- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
- (2015) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
- (2015) Valentin Goede et al. Oncology Research and Treatment
- Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas
- (2014) Marcus Remer et al. Immunotherapy
- Targeting CD137 enhances the efficacy of cetuximab
- (2014) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- KIR/HLA Interactions Negatively Affect Rituximab- but Not GA101 (Obinutuzumab)-Induced Antibody-Dependent Cellular Cytotoxicity
- (2014) G. Terszowski et al. JOURNAL OF IMMUNOLOGY
- CDD: NCBI's conserved domain database
- (2014) Aron Marchler-Bauer et al. NUCLEIC ACIDS RESEARCH
- Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
- (2014) Lin-Fang Wang et al. ONCOLOGY REPORTS
- EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
- (2014) B. Miao et al. Cancer Discovery
- The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
- (2014) Ross Stewart et al. Journal for ImmunoTherapy of Cancer
- Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
- (2013) R. M. Srivastava et al. CLINICAL CANCER RESEARCH
- EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion
- (2013) Nami Sugiyama et al. JOURNAL OF CELL BIOLOGY
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab
- (2012) C. A. Gerdes et al. CLINICAL CANCER RESEARCH
- Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
- (2012) Ruth Holm et al. International Journal of Medical Sciences
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- (2012) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
- (2011) William M. Merritt et al. CANCER BIOLOGY & THERAPY
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- (2010) H. E. Kohrt et al. BLOOD
- The Metastasis-Associated microRNA miR-516a-3p Is a Novel Therapeutic Target for Inhibiting Peritoneal Dissemination of Human Scirrhous Gastric Cancer
- (2010) Yoshifumi Takei et al. CANCER RESEARCH
- Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck
- (2010) Yong Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer
- (2009) J. M. Brannan et al. CLINICAL CANCER RESEARCH
- EFNA1 ligand and its receptor EphA2: Potential biomarkers for hepatocellular carcinoma
- (2009) Xiang-Dan Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients
- (2008) Wei-Jie Yuan et al. DIGESTIVE DISEASES AND SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started